These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3326159)

  • 41. Detection of bacterial signal by 16S rRNA polymerase chain reaction in expressed prostatic secretions predicts response to antibiotic therapy in men with chronic pelvic pain syndrome.
    Shoskes DA; Shahed AR
    Tech Urol; 2000 Sep; 6(3):240-2. PubMed ID: 10963501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Co-trimoxazole concentration in the prostatic fluid of patients with subacute and chronic prostatitis].
    Hofstetter A; Friesen A; Bishop-Freudling GB; Vergin H
    Fortschr Med; 1984 Mar; 102(9):244-6. PubMed ID: 6608482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rosamicin--a new drug for the treatment of bacterial prostatitis.
    Baumueller A; Hoyme U; Madsen PO
    Antimicrob Agents Chemother; 1977 Aug; 12(2):240-2. PubMed ID: 332074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Penetration of nitroxoline in the prostatic parenchyma. Therapeutic trial (proceedings)].
    Dufour A; Bollack C
    J Urol Nephrol (Paris); 1979 Mar; 85(3):207-12. PubMed ID: 113556
    [No Abstract]   [Full Text] [Related]  

  • 45. [Urotractin in the treatment of an infection of the kidneys, urinary tract and prostate].
    Lopatkin NA; Trapeznikova MF; Mazo EB; Derevianko II; Sobolevskiĭ AB; Dolzhenok AN; Meshkov VV
    Urol Nefrol (Mosk); 1997; (5):3-5. PubMed ID: 9412011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical studies of tosufloxacin on chronic bacterial prostatitis].
    Ikeuchi T; Kawamura N; Suzuki K; Onodera S; Osada T; Hirano A; Satomi Y; Yoshimura S; Yamamoto Y
    Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Olapade-Olaopa EO; Adebayo SA
    J Urol; 2006 Jun; 175(6):2365-6; author reply 2366. PubMed ID: 16697876
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical efficacy of ofloxacin (tarivid) in patients with chronic bacterial prostatitis: preliminary results.
    Pust RA; Ackenheil-Koppe HR; Gilbert P; Weidner W
    J Chemother; 1989 Jul; 1(4 Suppl):869-71. PubMed ID: 16312678
    [No Abstract]   [Full Text] [Related]  

  • 49. National guideline for the management of prostatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
    Sex Transm Infect; 1999 Aug; 75 Suppl 1():S46-50. PubMed ID: 10616384
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
    J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic bacterial prostatitis: theoretical and experimental considerations.
    Madsen PO; Jensen KM; Iversen P
    Urol Res; 1983; 11(1):1-5. PubMed ID: 6344395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic pharmacokinetics in the inflamed prostate.
    Nickel JC; Downey J; Clark J; Ceri H; Olson M
    J Urol; 1995 Feb; 153(2):527-9. PubMed ID: 7815638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial treatment of prostatitis.
    Wagenlehner FM; Naber KG
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):275-82. PubMed ID: 15482123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacterial prostatitis: new methods of treatment.
    Aagaard J; Madsen PO
    Urology; 1991; 37(3 Suppl):4-8. PubMed ID: 2003343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacotherapeutic interventions for the treatment of bacterial prostatitis.
    Marquez-Algaba E; Burgos J; Almirante B
    Expert Opin Pharmacother; 2022 Jun; 23(9):1091-1101. PubMed ID: 35574695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The passage of antibiotics into prostatic secretions: theoretical and experimental study. Apropos of a new urinary antibiotic: oxolinic acid (proceedings)].
    Richard F; Khoury S; Lambert-Zechovsky N; Bingen E; Küss R
    J Urol Nephrol (Paris); 1979 Mar; 85(3):199-206. PubMed ID: 39178
    [No Abstract]   [Full Text] [Related]  

  • 57. Prostatitis: ancient history and new horizons.
    Krieger JN; Weidner W
    World J Urol; 2003 Jun; 21(2):51-3. PubMed ID: 12721753
    [No Abstract]   [Full Text] [Related]  

  • 58. [Proposed therapeutic attitude in chronic prostatitis from the viewpoint of pathogenesis and pathological anatomy (proceedings)].
    Motz C; Jaupitre M
    J Urol Nephrol (Paris); 1979 Mar; 85(3):231-5. PubMed ID: 480422
    [No Abstract]   [Full Text] [Related]  

  • 59. Antimicrobial substances in secretion, interstitial fluid, and tissue of normal and infected canine prostate glands.
    Baumueller A; Madsen PO
    Urol Res; 1982 Feb; 10(1):31-5. PubMed ID: 7200274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penetration of antimicrobial agents into the prostate.
    Charalabopoulos K; Karachalios G; Baltogiannis D; Charalabopoulos A; Giannakopoulos X; Sofikitis N
    Chemotherapy; 2003 Dec; 49(6):269-79. PubMed ID: 14671426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.